Faculty, Staff and Student Publications
Publication Date
9-26-2023
Journal
Cell Reports
Abstract
The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements with pheochromocytomas carrying mutations of the tyrosine kinase receptor RET. Additionally, TMEM127-mutant pheochromocytomas, human cells, and mouse knockout models of TMEM127 accumulate RET and increase its signaling. TMEM127 contributes to RET cellular positioning, trafficking, and lysosome-mediated degradation. Mechanistically, TMEM127 binds to RET and recruits the NEDD4 E3 ubiquitin ligase for RET ubiquitination and degradation via TMEM127 C-terminal PxxY motifs. Lastly, increased cell proliferation and tumor burden after TMEM127 loss can be reversed by selective RET inhibitors in vitro and in vivo. Our results define TMEM127 as a component of the ubiquitin system and identify aberrant RET stabilization as a likely mechanism through which TMEM127 loss-of-function mutations cause pheochromocytoma.
Keywords
Cp: Cancer, Nedd4, Ret, Tmem127, Degradation, Oncogene, Paraganglioma, Pheochromocytoma, Positioning, Single-Nucleus Sequencing, Tumor Suppressor Gene, Ubiquitin
DOI
10.1016/j.celrep.2023.113070
PMID
37659079
PMCID
PMC10637630
PubMedCentral® Posted Date
November 2023
PubMedCentral® Full Text Version
Author MSS
Comments
Associated Data